Part, Chapter, Paragraph
1 II, 5. 1. 1| factors: chemicals in the brain that control hunger, appetite,
2 II, 5. 5 | 5.5. Mental and brain diseases and disorders~ ~
3 II, 5. 5.Int| attributable to mental and brain disorders will rise to 15%13.
4 II, 5. 5. 2| describe various kinds of brain disorders which all involve
5 II, 5. 5. 2| progressive damage and death of brain cells. It is not actually
6 II, 5. 5. 2| structure and chemistry of the brain gradually becomes severely
7 II, 5. 5. 2| post-mortem examination of the brain. The statistics presented
8 II, 5. 5. 2| for you – good for your brain: the evidence on risk reduction
9 II, 5. 5. 2| Can dementia be prevented? Brain aging in a population-based
10 II, 5. 5. 3| Degeneration~EBC~European Brain Council~GP~General practitioner~
11 II, 5. 5. 3| factors: chemicals in the brain that control hunger, appetite,
12 II, 5. 5. 3| functional disturbances of the brain. Therefore, and due to the
13 II, 5. 5. 3| available. Yet the European Brain Council has evaluated the
14 II, 5. 5. 3| has evaluated the costs of brain disorders in Europe by an
15 II, 5. 5. 3| Direct healthcare costs by brain disorder~The most comprehensive
16 II, 5. 5. 3| evaluation of costs for brain disorders was performed
17 II, 5. 5. 3| performed by the European Brain Council (Figure 5.5.3.3.
18 II, 5. 5. 3| Cost of disorders of the brain in Europe. Eur J Neurol
19 II, 5. 5. 3| They also have abnormal brain wave patterns which can
20 II, 5. 5. 3| from a number of disordered brain functions. The cardinal
21 II, 5. 5. 3| recurrent paroxysmal episodes of brain dysfunction characterized
22 II, 5. 5. 3| occur in the context of a brain insult (systemic, toxic
23 II, 5. 5. 3| CNS abnormalities such as brain tumours, genetic, metabolic
24 II, 5. 5. 3| to those aged 65 or more. Brain tumors, cerebrovascular
25 II, 5. 5. 3| epilepsy in Kaunas, Lithuania. Brain Dev 19:379-387.~Eriksson
26 II, 5. 5. 3| with multiple sclerosis. Brain 127:844-850.~Brønnum-Hansen
27 II, 5. 5. 3| sclerosis: an amnesic process. Brain 126:770–782.~Dahl OP, Aarseth
28 II, 5. 5. 3| heterogeneity on pathogenesis. Brain Pathol 6:259-274.~Mc Donald
29 II, 5. 5. 3| degeneration of neurons in the brain area substantial nigra pars
30 II, 5. 5. 3| calculate the burden of brain disorders estimated the
31 II, 5. 5. 3| promoted by the European Brain Council (ECB), estimated
32 II, 5. 5. 3| estimated the costs of brain disorders in the different
33 II, 5. 5. 3| demonstrate that the costs for brain disorders are generally
34 II, 5. 5. 3| Consortium, 2004)~The European Brain Council (EBC) has launched
35 II, 5. 5. 3| understanding but also awareness of brain disorders in Europe (htt ).
36 II, 5. 5. 3| health economic evaluation of brain disorders in Europe (Andlin-Sobocki
37 II, 5. 5. 3| Cost of disorders of the brain in Europe. Eur J Neurol
38 II, 5. 5. 3| A community-based study. Brain 123:2297-2305.~Singer E (
39 II, 5. 5. 3| Acronyms~ ~EBC~European Brain Council~GP~General practitioner~
40 II, 8. 2. 1| by injury, disease, or a brain abnormality. These causes
41 II, 8. 2. 1| defects that affect the brain (such as hydrocephalus or
42 II, 8. 2. 1| prevent certain kinds of brain abnormalities. Advances
43 II, 9. 1. 1| the developing/immature brain (DMCN, 2000).~ ~Challenges
44 II, 9. 1. 2| trimester of pregnancy (brain development continues later),
45 II, 9. 3. 1| response to toxins;~· brain organisation; and~· the
46 II, 9. 3. 1| for prostate problems.~ ~Brain function, mental health,
47 II, 9. 3. 1| time of menopause. In the brain and eye, as in other target
48 II, 9. 3. 1| that sex hormones influence brain function throughout life,
49 III, 10. 2. 1| Childen~Adults~Larinx~Stroke~Brain tumors*~Stroke*~Oropharinx~
50 III, 10. 2. 1| bloodstream and enters in the brain. Immediately after exposure
51 III, 10. 2. 1| has several effects on the brain. The activation of reward
52 III, 10. 2. 1| of reward pathways, the brain circuitry that regulates
53 III, 10. 2. 1| and a decreased volume of brain grey matter.~ ~Long term
54 III, 10. 2. 1| and selenoproteins in the brain and brain diseases. J Neurochem.
55 III, 10. 2. 1| selenoproteins in the brain and brain diseases. J Neurochem. 86:
56 III, 10. 2. 5| Indredavik et al, 2007).~Human brain development is vulnerable.
57 III, 10. 2. 5| Black 1998). Even though brain continues maturation till
58 III, 10. 2. 5| development of the infant's brain and even formation of permanent
59 III, 10. 2. 5| fetal development can cause brain injury at doses much lower
60 III, 10. 2. 5| than those affecting adult brain function. Recognition of
61 III, 10. 2. 5| in the developing human brain are not known and they are
62 III, 10. 2. 5| How a child builds its brain: Some lessons from animal
63 III, 10. 3. 1| neurodegenerative diseases and brain tumours, the link to ELF
64 III, 10. 3. 1| pose any increased risk of brain tumour or acoustic neuroma.
65 III, 10. 3. 1| is no increased risk for brain tumours in long-term users,
66 III, 10. 3. 2| foetal development can cause brain injury at doses much lower
67 III, 10. 3. 2| than those affecting adult brain function. Recognition of
68 III, 10. 3. 2| in the developing human brain are not known and they are
69 III, 10. 3. 3| mainly localized in the brain and other parts of the nervous
70 III, 10. 5. 3| Costs of disorders of the brain in Europe. European Journal
71 IV, 11. 3. 1| Migration Outlook examined the “brain drain” of doctors from lower-income
72 IV, 13. 7. 3| medicine, virology, and brain & behaviour, significant
73 IV, 13. 9 | Cost of disorders of the brain in Europe. Eur J Neurol
74 Key, Ap5. 0. 0| botulinum~botulism~bowel~brain~breast~breast-fed~breastfeeding~